Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,23 USD | -2,04% |
|
+7,68% | -13,83% |
08/07 | CASI Pharmaceuticals nomina Daniel Lang CFO | MT |
08/07 | CASI Pharmaceuticals, Inc. nomina Daniel Lang come Vicepresidente senior | CI |
Attività
Numero di dipendenti: 176
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 43 | 100,0 % | 34 | 100,0 % | -21,41% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 43 | 100,0 % | 34 | 100,0 % | -21,41% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 02/04/19 |
Wei Zhang
PSD | President | 64 | 01/09/18 |
Chun Hua Wang
COO | Chief Operating Officer | 52 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 65 | 01/04/17 | |
Wei Gao
LAW | General Counsel | 42 | 01/01/23 |
Kun Qian
AUD | Comptroller/Controller/Auditor | 42 | 01/01/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 02/04/19 |
Yue Wu
BRD | Director/Board Member | 62 | 01/04/13 |
Zhen Bo Su
BRD | Director/Board Member | 48 | 21/03/23 |
Thomas Folinsbee
BRD | Director/Board Member | 57 | 21/03/23 |
Xue Bo Zeng
BRD | Director/Board Member | 39 | 21/03/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 13 813 327 | 8 607 899 ( 62,32 %) | 411 952 ( 2,982 %) | 62,32 % |
Coordinate società
CASI Pharmaceuticals, Inc.
1701-1702, China Central Office Tower 1, No. 81 Jianguo Road
100025, Beijing
+
http://www.casipharmaceuticals.com![Indirizzo CASI Pharmaceuticals, Inc.(CASI)](https://cdn.zonebourse.com/static/address/16699864.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-13,83% | 82,61 Mln | |
+62,60% | 841 Mrd | |
+40,42% | 625 Mrd | |
-3,82% | 360 Mrd | |
+17,50% | 327 Mrd | |
+10,45% | 300 Mrd | |
+15,66% | 242 Mrd | |
+17,90% | 227 Mrd | |
+15,85% | 174 Mrd | |
+1,08% | 162 Mrd |
- Borsa valori
- Azioni
- Azione CASI
- Società CASI Pharmaceuticals, Inc.